Viral IL-10 (vIL-10), the IL-10 homologue of Epstein-Barr virus, has so far
been described as a cytokine that solely inhibits T cell function. Here we
show in vivo and in vitro that after longterm secretion vIL-10 has a stimu
latory effect on T cells. For this purpose we employed transfectants derive
d from a mastocytoma cell line (P815 cells, H-2(d)) constitutively secretin
g vIL-10 (P815-vIL-10) or expressing the co-stimulatory molecule B7-1 (P815
-B7). After in vitro stimulation of splenocytes from syngeneic DBA/2 mice f
or 7 days in the presence of P815-vIL-10 cells we could detect a marked red
uction of proliferation as well as cytotoxicity against P815 target cells.
However, this inhibitory effect was reversed when stimulation with P815-vIL
-10 cells was extended to 14 days. In vivo P815-vIL-10 cells were rejected
whereas P815 cells transfected with a control plasmic were tumorigenic afte
r injection into syngeneic DBA/2 mice. Furthermore, this stimulatory effect
of constitutive vIL-10 secretion could be exploited to irradicate already
established P815 tumors which were smaller than 5 x 5 mm. In contrast, para
crine vIL-10 secretion for a limited time period of 8-9 days was associated
with inhibitory effects in vivo: P815-B7 cells, which are normally elimina
ted in DBA/2 mice, could grow if exposed to temporarily secreted vIL-10 . T
hese time-dependent immunomodulatory effects have to be considered in poten
tial therapeutic applications of vIL-10.